Evidence map›Paper›PMID 34262099›Full record

ArticleScientific reports2021

MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cells.

Sofia Zanotti, Suzanne Vanhauwaert, Christophe Van Neste, Volodimir Olexiouk, Jolien Van Laere, Marlies Verschuuren, Joni Van der Meulen, Liselot M Mus, Kaat Durinck, Laurentijn Tilleman and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Cellular senescence in neuroblastoma.British journal of cancer · 2022
    Review
  7. Regulation of 3D Organization and Its Role in Cancer Biology.Frontiers in cell and developmental biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Sofia ZanottiLaboratory of Cell Biology and Histology, Dept. Veterinary Sciences, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium.
Suzanne VanhauwaertCenter for Medical Genetics, Dept. Biomolecular Medicine, Ghent University, Medical Research Building (MRB), 2nd Floor, Entrance 34, Corneel Heymanslaan 10, 9000, Ghent, Belgium.
Christophe Van NesteCenter for Medical Genetics, Dept. Biomolecular Medicine, Ghent University, Medical Research Building (MRB), 2nd Floor, Entrance 34, Corneel Heymanslaan 10, 9000, Ghent, Belgium.
Volodimir OlexioukCenter for Medical Genetics, Dept. Biomolecular Medicine, Ghent University, Medical Research Building (MRB), 2nd Floor, Entrance 34, Corneel Heymanslaan 10, 9000, Ghent, Belgium.
Jolien Van LaereCenter for Medical Genetics, Dept. Biomolecular Medicine, Ghent University, Medical Research Building (MRB), 2nd Floor, Entrance 34, Corneel Heymanslaan 10, 9000, Ghent, Belgium.
Marlies VerschuurenLaboratory of Cell Biology and Histology, Dept. Veterinary Sciences, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium.
Joni Van der MeulenCenter for Medical Genetics, Dept. Biomolecular Medicine, Ghent University, Medical Research Building (MRB), 2nd Floor, Entrance 34, Corneel Heymanslaan 10, 9000, Ghent, Belgium.
Liselot M MusCenter for Medical Genetics, Dept. Biomolecular Medicine, Ghent University, Medical Research Building (MRB), 2nd Floor, Entrance 34, Corneel Heymanslaan 10, 9000, Ghent, Belgium.
Kaat DurinckCenter for Medical Genetics, Dept. Biomolecular Medicine, Ghent University, Medical Research Building (MRB), 2nd Floor, Entrance 34, Corneel Heymanslaan 10, 9000, Ghent, Belgium.
Laurentijn TillemanCancer Research Institute Ghent (CRIG), Ghent University, 9000, Ghent, Belgium.
Dieter DeforceCancer Research Institute Ghent (CRIG), Ghent University, 9000, Ghent, Belgium.
Filip Van NieuwerburghCancer Research Institute Ghent (CRIG), Ghent University, 9000, Ghent, Belgium.
Michael D HogartyChildren's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Bieke Decaesteker *Center for Medical Genetics, Dept. Biomolecular Medicine, Ghent University, Medical Research Building (MRB), 2nd Floor, Entrance 34, Corneel Heymanslaan 10, 9000, Ghent, Belgium.
Winnok H De Vos *Laboratory of Cell Biology and Histology, Dept. Veterinary Sciences, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium.
Frank SpelemanCenter for Medical Genetics, Dept. Biomolecular Medicine, Ghent University, Medical Research Building (MRB), 2nd Floor, Entrance 34, Corneel Heymanslaan 10, 9000, Ghent, Belgium. franki.speleman@ugent.be.
Cancer Research Institute Ghent · BEGhent University Hospital · BEGhent University · BEUniversity of Antwerp · BEUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MYCN is an oncogenic driver in neural crest-derived neuroblastoma and medulloblastoma. To better understand the early effects of MYCN activation in a neural-crest lineage context, we profiled the transcriptome of immortalized human retina pigment epithelial cells with inducible MYCN activation. Gene signatures associated with elevated MYC/MYCN activity were induced after 24 h of MYCN activation, which attenuated but sustained at later time points. Unexpectedly, MYCN activation was accompanied by reduced cell growth. Gene set enrichment analysis revealed a senescence-like signature with strong induction of p53 and p21 but in the absence of canonical hallmarks of senescence such as β-galactosidase positivity, suggesting incomplete cell fate commitment. When scrutinizing the putative drivers of this growth attenuation, differential gene expression analysis identified several regulators of nucleolar stress. This process was also reflected by phenotypic correlates such as cytoplasmic granule accrual and nucleolar coalescence. Hence, we propose that the induction of MYCN congests the translational machinery, causing nucleolar stress and driving cells into a transient pre-senescent state. Our findings shed new light on the early events induced by MYCN activation and may help unravelling which factors are required for cells to tolerate unscheduled MYCN overexpression during early malignant transformation.

Indexed as

Cell NucleolusCellular SenescenceN-Myc Proto-Oncogene ProteinRetinal Pigment EpitheliumTelomeraseCell LineCell ProliferationHumansStress, PhysiologicalTranscriptomeMYCN protein, humanN-Myc Proto-Oncogene ProteinTelomeraseTERT protein, human

Identifiers

PMID34262099
PMCPMC8280219
OpenAlexW3179720119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.